This meeting took place in 2014


Here are the related meetings in 2019:
HIV Vaccines (X7)

For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.

HIV Vaccines: Adaptive Immunity and Beyond (X3)


Organizer(s) Nicole Frahm, Susan W. Barnett and Galit Alter
March 9—14, 2014
Fairmont Banff Springs • Banff, Alberta Canada
Discounted Abstract Deadline: Nov 7, 2013
Abstract Deadline: Dec 11, 2013
Scholarship Deadline: Nov 7, 2013
Discounted Registration Deadline: Jan 10, 2014

Sponsored by Sangamo BioSciences, Inc. Part of the Keystone Symposia Global Health Series, supported by the Bill & Melinda Gates Foundation


Summary of Meeting:
The HIV vaccine field has undergone dramatic changes over the last several years: from the failure of the promising MRKAd5-HIV-1 vaccine to provide any protection from acquisition or disease progression to the first demonstration that an HIV vaccine can actually show efficacy with a regimen that was predicted to fail in RV144. Following these developments, the field has turned from T-cell based vaccines favored for the late nineties/early 2000s back to antibody-inducing strategies, although with a reduced focus on broadly neutralizing antibodies since these were not detected in RV144 vaccinees. This meeting aims at bringing the cellular and humoral factions together to work on a holistic approach to HIV vaccination: induction of antibodies – both binding and neutralizing – to prevent infection; a safety net of CD8 T-cell responses to control viral replication in those hosts that do become infected; and CD4 T cell help for both effector arms. In addition, we seek to provide a better understanding of the interplay of innate immune responses and the resulting adaptive response, as well as a closer look at the signals that are crucial for the induction of long-lasting memory responses. This comprehensive approach to vaccinology will be complemented by a thorough portrayal of HIV transmission, both from the viral perspective as well as the portal of entry; and by a closer look of how vaccines interact with the host’s genetic profile. Taken together, this meeting will bring scientists from all denominations together to tackle the design of a new generation of highly effective HIV vaccines.

View Meeting Program

Scholarships/Awards

Biogen Idec ECITA Scholarship Recipients

Qiana Matthews
University of Alabama, Birmingham, USA

Keystone Symposia Future of Science Fund Scholarship Recipients

Thomas Musich
DHHS, National Institutes of Health, USA

National Institute of General Medical Sciences (NIGMS) Ancillary Training Program Scholarship Recipients

Anitra L. Farrow
University of Alabama, Birmingham, USA

Tamika L. Payne
Duke University, USA

Lorenzo Antonio Ramirez
University of Pennsylvania, USA

Samantha Marie Townsley
Walter Reed Army Institute of Research, USA

Richard Watkins
University of North Carolina at Chapel Hill, USA

National Institute of Allergy and Infectious Diseases (NIAID) Scholarship Recipients

Rena D. Astronomo
Fred Hutchinson Cancer Research Center, USA

Rafael Cubas
Vaccine and Gene Therapy Institute Florida, USA

Anne-Sophie M. Dugast
Ragon Institute of MGH, MIT and Harvard, USA

Frank Liang
Karolinska Institutet, Sweden

Vijaya Madhavi
University of Melbourne, Australia

Emily E.I.M. Mouser
Academisch Medisch Centrum, AMC, Netherlands

Zakiya Qualls
Rutgers Biomedical and Health Sciences, USA

Torben Schiffner
The Scripps Research Institute, USA

Jeffrey Robert Schneider
Northwestern University, USA

Liang Shang
University of Minnesota, USA

Keystone Symposia Global Health Travel Award Recipients, funded by the Bill & Melinda Gates Foundation
Funded by Keystone Symposia Global Health Travel Award Recipients, funded by the Bill & Melinda Gates Foundation

Seid Mussa Ahmed
Jimma University, Ethiopia

Maira da Costa Cacemiro
Universidade de São Paulo - USP, Brazil

Samuel Adetona Fayemiwo
University of Ibadan, Nigeria

Rajesh Abraham Jacob
ICGEB, University of Cape Town, South Africa

Tsungai Ivai Jongwe
University of Cape Town, South Africa

Jacqueline Kyosiimire-Lugemwa
Medical Research Council, Uganda, Uganda

Gladys Njeri Macharia
Imperial College London, UK

Eunice Wambui Nduati
KEMRI, Wellcome Trust, Kenya

Matthew Obaineh Ojezele
Delta State University, Abraka, Nigeria

Iheanyi Omezuruike Okonko
University of Port Harcourt, Nigeria, Nigeria

Betty Auma Oliver
Uganda Virus Research Institute, Uganda

Mohammad Arif Rahman
National Cancer Institute, USA

Essomba Rene Ghislain
International Centre for Genetic Engineering and Biotechnology, South Africa

Catherine Riou
University of Cape Town, South Africa

Aime Marcel Simon Tongo Passo
University of Cape Town, South Africa